Results 211 to 220 of about 300,285 (315)

Plasma-derived exosomal miR-34a-5p: a potential diagnostic biomarker for total colonic aganglionosis. [PDF]

Transl Pediatr
Wang J, Hong Z, Wu Z, Liu J, Chen J.
europepmc   +1 more source

<p>MicroRNA-374b-5p Functions as a Tumor Suppressor in Non-Small Cell Lung Cancer by Targeting FOXP1 and Predicts Prognosis of Cancer Patients</p>

, 2020
Jianzhao Li, Xinfang Zhang, Jiaying Tang, Cuixue Gong   +3 more
openalex   +2 more sources

Mucin Glycoprotein Nanoparticles Enable a Selective Antisense Therapy for Oncogenic MicroRNAs

Advanced NanoBiomed Research, EarlyView.
Mucin glycoproteins are turned into nanoparticles by employing synthetic DNA strands, which have a dual function: they stabilize the nanoparticles and act as binding sites for intracellular miRNA‐21. Thus, upon internalization into tumor cells, these mucin nanoparticles can deplete miRNA‐21 from the cytosol, which induces apoptosis in vitro and in vivo.
Ceren Kimna, Thomas Mayer, Di Zhang, Matthias Marczynski, Carolin A. Rickert, Fabio Henkel, Lennart J. K. Weiss, Friedrich C. Simmel, Yuxia Luan, Oliver Lieleg   +9 more
wiley   +1 more source

MicroRNA profiling of testicular Leydig cell tumors identifies a microRNA signature associated with malignancy and miR-196b-5p as a potentially useful biomarker. [PDF]

J Pathol
Lobo J, Tavares NT, Fernandes-Pontes F, Constâncio V, Marques AT, Oliveira-Lopes B, Fonseca D, Jerónimo C, Henrique R, Michalova K, Cornejo KM, Colecchia M, Ricci C, Idrees MT, Contreras F, Gonzalez IMF, Anderson WJ, MacLean F, Osunkoya AO, Kao CS, Sangoi AR, Ulbright TM, Acosta AM.   +22 more
europepmc   +1 more source

Decoding the Pathophysiology of Autoimmune Diseases—Mechanism, Triggers, and Nanotherapeutics: A Review

Advanced NanoBiomed Research, EarlyView.
This review highlights how autoimmune diseases arise from intertwined immunological, genetic, and environmental factors, emphasizing gut microbiota dysbiosis as a pivotal driver. It outlines emerging nanotechnology‐based strategies—such as liposomes, hydrogels, and polymeric nanoparticles—that enhance targeted drug delivery, minimize systemic toxicity,
Md. Meraj Ansari, Yunhui Min, Eun‐Ju Ko, Doyoung Kwon, Rehan Khan, Young‐Ok Son   +5 more
wiley   +1 more source

Circulating MicroRNA Biomarkers for Chronic Pain and Acupuncture Response: An Exploratory High-Dimensional Small-Sample Study. [PDF]

J Pain Res
Kang IH, Kim SN.
europepmc   +1 more source

MicroRNAs [PDF]

Genome Biology, 2002
openaire   +1 more source

Research Trends and Insights Regarding MicroRNAs in Psoriasis: A Comprehensive Analysis. [PDF]

Cureus
Örs I, Cosansu NC, Solak B.
europepmc   +1 more source

Correction to "Astaxanthin Modulates Inflammation in Type 2 Diabetes via Regulation of microRNAs, Lysophosphatidylcholine, and α-Hydroxybutyrate". [PDF]

Int J Endocrinol
europepmc   +1 more source

Nanoclay‐Engineered Scaffolds for the Controlled Delivery of Biomolecules in Regenerative Medicine

Asia-Pacific Journal of Chemical Engineering, EarlyView.
ABSTRACT Regenerative medicine combines biomaterials, cells, scaffolds, and bioactive agents via modern technologies to aid in the reconstruction and repair of damaged tissues. Among these, nanoclay scaffolds have demonstrated unique advantages in facilitating the delivery of therapeutic agents.
Mehri Shadi, Saeed Vafaei‐Nezhad, Ahmad Gholamalizadeh Ahangar   +2 more
wiley   +1 more source